Overweight and obesity are contributing to rising death rates from bowel cancer among people aged 25–49 years in the European Union (EU) and the UK, although death rates from this type of cancer are decreasing overall across ...
Jan 28, 2024
0
20
In a study published in the journal Eco-Environment & Health, researchers from Tsinghua University used modeled NO2 exposure concentrations, exposure-response relationships with lung cancer, chronic obstructive pulmonary ...
Jan 26, 2024
0
0
Researchers from seven Environment for Development (EfD) centers plus the EfD Global Hub, located at the University of Gothenburg, have conducted an extensive survey on how serious people perceive COVID-19.
Jan 26, 2024
0
20
On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new brief report in Oncoscience titled "My battle with cancer. Part 1."
Jan 22, 2024
0
0
Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly-used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.
Jan 22, 2024
0
15
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
A new Cleveland Clinic study shows there are disparities in cancer research and advocacy funding and that less funding strongly correlates with fewer clinical trials in a particular disease.
Jan 9, 2024
0
0
Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year. Over the ...
Jan 8, 2024
0
0
Research published in Journal of Shanghai Jiao Tong University (Science) has proposed a new method for lung image registration named Dlung. Dlung is an unsupervised few-shot learning-based diffeomorphic lung image registration, ...
Jan 7, 2024
0
6
A phase III LIBRETTO-431 multicenter study has evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune ...
Jan 5, 2024
0
1
